Omega-3–based treatment to reduce inflammation signals in blood cells
Part of Immune system & allergy clinical trials.
This trial studies an omega-3–based approach to boost the body’s natural “inflammation-resolving” activity in certain blood immune cells. It may help people who want to see whether this strategy can improve inflammation-related biology.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older.
- You should not have taken omega-3 supplements within 7 days before starting the study.
- You should not have taken anti-inflammatory medicines within 7 days before starting the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a special form of omega-3 (MAG-EPA) can help people with ongoing brain fog symptoms like mental fatigue, memory loss, or trouble concentrating. If you've had these issues for at least 28 days, you may be eligible.
This study tests whether omega-3 fatty acids can reduce inflammation and improve immune function in older adults with blockages in blood vessels. If you qualify, you may take a daily pill for several months to see if it helps your body's defenses work better.
This trial tests whether an oral supplement made from special fats (called Specialized Pro-resolving Mediators) can help reduce blood vessel damage caused by inflammation in people with obesity and high blood pressure. If you have well-controlled high blood pressure and are obese, you may be able to join.
This trial tests whether a magnolia dietary supplement can improve immune markers in people with psoriasis. If you have stable psoriasis (for at least 6 months) and are not using certain strong medications, you may be able to participate from home by using a smartphone app and mailing blood samples.
This trial compares a new phospholipid omega-3 supplement with a regular omega-3 supplement to see which works better for people with mixed dyslipidemia (high cholesterol and triglycerides) and high inflammation markers. It may help lower your triglyceride levels and reduce heart-related risks.
This study looks at how omega-3 supplements affect certain fats in the blood of adults with obesity. Researchers want to see if taking these supplements changes these fats in a helpful way.
Hear when a new Resolution of Inflammation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.